PMID- 23425059 OWN - NLM STAT- MEDLINE DCOM- 20131216 LR - 20130522 IS - 1440-1746 (Electronic) IS - 0815-9319 (Linking) VI - 28 IP - 6 DP - 2013 Jun TI - Transition zone defect associated with the response to proton pump inhibitor treatment in patients with globus sensation. PG - 954-62 LID - 10.1111/jgh.12136 [doi] AB - BACKGROUND AND AIM: Few data describing short-term proton pump inhibitor (PPI) treatment in patients with globus sensation exist. The aim of this study was to evaluate the use of high-resolution manometry (HRM) for predicting the response to PPI treatment in patients with globus sensation. METHOD: A total of 41 patients with globus sensation were treated with PPIs for 4 weeks and were classified as positive and negative responders. HRM topographical plots were analyzed for relevant manometric parameters. In addition, clinical and HRM data of 20 patients with typical gastroesophageal reflux disease (GERD) not presenting globus symptom were analyzed. RESULTS: Of the 41 patients, 19 (46%) were clinically diagnosed with GERD. The proportion of patients with favorable symptomatic improvement was higher in patients with GERD than in those without reflux (P=0.046). Positive and negative responders to PPI treatment did not differ in upper esophageal sphincter and proximal esophageal contraction. In globus patients with GERD, the temporal and spatial dimension of the transitional zone were greater among negative responders than among PPI-positive responders (P=0.010 and P=0.011). Regarding GERD patients without globus, there was no significant difference in transition zone defect according to PPI responsiveness. By receiver operating characteristic curve analysis, 2.1 cm and 1.1 s were found to be the spatial and temporal transitional zone dimensions that best differentiated positive and negative responders. CONCLUSION: In patients with GERD-related globus, there were larger transition zone defect in the negative responders compared with the PPI-positive responders. CI - (c) 2013 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd. FAU - Han, Min Seok AU - Han MS AD - Department of Internal Medicine, Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea. FAU - Lee, Hyuk AU - Lee H FAU - Jo, Jung Hyun AU - Jo JH FAU - Cho, In Rae AU - Cho IR FAU - Park, Jun Chul AU - Park JC FAU - Shin, Sung Kwan AU - Shin SK FAU - Lee, Sang Kil AU - Lee SK FAU - Lee, Yong Chan AU - Lee YC LA - eng PT - Journal Article PL - Australia TA - J Gastroenterol Hepatol JT - Journal of gastroenterology and hepatology JID - 8607909 RN - 0 (Proton Pump Inhibitors) SB - IM MH - Deglutition Disorders/*physiopathology MH - Female MH - Humans MH - Male MH - *Manometry MH - Middle Aged MH - Proton Pump Inhibitors/*therapeutic use MH - Sensation EDAT- 2013/02/22 06:00 MHDA- 2013/12/18 06:00 CRDT- 2013/02/22 06:00 PHST- 2013/01/19 00:00 [accepted] PHST- 2013/02/22 06:00 [entrez] PHST- 2013/02/22 06:00 [pubmed] PHST- 2013/12/18 06:00 [medline] AID - 10.1111/jgh.12136 [doi] PST - ppublish SO - J Gastroenterol Hepatol. 2013 Jun;28(6):954-62. doi: 10.1111/jgh.12136.